CVC-backed System C completed the acquisition of CIS Oncology.

CVC-backed System C, a provider of healthcare and local government technology solutions, completed the acquisition of CIS Oncology, a chemotherapy prescription and management system. Financial terms were not disclosed. "We are delighted to welcome CIS Oncology to the System C family. This acquisition shows our commitment to delivering seamless care, prioritising patient and clinical safety, and forging stronger connections with our customers as they embrace digital solutions across health and social care. By integrating CIS Oncology’s expertise, we are now even better equipped to provide high-quality and cost-effective ePrescribing solutions that not only meet our customers’ needs but reinforce our dedication to the NHS and our UK-centric approach. We’re looking forward to working together with CIS Oncology to leverage our collective expertise to significantly transform healthcare and shape the future of patient care," Nick Wilson, System C CEO.